The Swedish CArdioPulmonary bioImage Study – SCAPIS – is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
The aim is to predict and prevent cardiovascular and pulmonary disease. A total of 30,154 men and women in Sweden, from 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The first public release of data was on March 17, 2021. All researchers based in Sweden, or international researchers in collaboration with an applicant based in Sweden, are welcome to apply for data.
SCAPIS 2 – re-examination
A major focus of the study is presently to prepare for a re-examination of half the cohort, SCAPIS 2. The same study protocol will be used as in the core study, SCAPIS 1. SCAPIS 2 will start in Gothenburg in January 2024, followed by the other five sites during spring. The planned end date of the study is in February 2026 and the ambition from the study is to start sharing data six months after that, i.e. in September 2026.